Equities

Endonovo Therapeutics Inc

ENDV:PKC

Endonovo Therapeutics Inc

Actions
  • Price (USD)0.0011
  • Today's Change0.000 / -20.00%
  • Shares traded201.00k
  • 1 Year change-89.33%
  • Beta-0.6122
Data delayed at least 15 minutes, as of Sep 20 2024 19:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Directors & dealings data is unavailable for this security.

Directors & Officers

Click or tap a row for biographies

NameTitleCompensationAgeOfficer since
Ira WeisbergPresident, Chief Commercial Officer - Medical Division----2022
Alan CollierChief Executive Officer, Interim Chief Financial Officer, Secretary, Director270.00kUSD502012
Nevena ZubcevikChief Medical Officer----2019
Steven BarnesIR Contact Officer------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.